Profound Medical Corp. (PROF) stock
PROFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$7.85+0.17 (+2.21%)
Close on Nov 11, 2026Market cap $286.78MP/E –Yield –
Profound Medical gross margin
Gross margin is gross profit as a percentage of revenue.
Profound Medical's gross margin for the twelve months ending Sep 30, 2026 was 73.9%. For fiscal 2025 it was 70.8%, against 65.9% the year before. The highest annual figure on record is 70.8% in fiscal 2025.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 70.8% | +4.9 |
| FY2024 | Dec 31, 2024 | 65.9% | +6.0 |
| FY2023 | Dec 31, 2023 | 59.9% | +14.7 |
| FY2022 | Dec 31, 2022 | 45.2% | +2.3 |
| FY2021 | Dec 31, 2021 | 43.0% | −4.6 |
| FY2020 | Dec 31, 2020 | 47.6% | −9.7 |
| FY2019 | Dec 31, 2019 | 57.3% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 78.1% | +3.8 |
| Q2 FY2026 | Jun 30, 2026 | 78.4% | +5.2 |
| Q1 FY2026 | Mar 31, 2026 | 71.8% | +1.1 |
| Q4 FY2025 | Dec 31, 2025 | 66.8% | −4.2 |
| Q3 FY2025 | Sep 30, 2025 | 74.3% | +11.2 |
| Q2 FY2025 | Jun 30, 2025 | 73.2% | +9.5 |
| Q1 FY2025 | Mar 31, 2025 | 70.7% | +10.5 |
| Q4 FY2024 | Dec 31, 2024 | 70.9% | – |
| Q3 FY2024 | Sep 30, 2024 | 63.1% | – |
| Q2 FY2024 | Jun 30, 2024 | 63.6% | – |
| Q1 FY2024 | Mar 31, 2024 | 60.2% | – |
See a number that looks wrong?